A.D.A.M.
OperatingAdvanced Development of Additive Manufacturing, Inc.
Software & AI · Stamford, DE · Founded 2019
An on-demand personalized implant manufacturing infrastructure
Financials
FY2019–FY2022 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round. Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Share counts as of Dec 31, 2020| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Stock | 8,535,791 | — | 100.0% | $901.00Sep 2019 |
Shares outstanding over timein today's share terms
Principal holders% as the filing states it, Apr 29, 2022
- Denys Gurak4,653,935 Common Stock43.4%of company
- Kwambio, Inc.3,366,585 Common Stock31.4%of company
Sold to the crowd
- Reg CF · Nov 202143,323 shares at $2.93$126.9K· 163 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
7 people
Denys is a former top executive of industrial conglomerates and an expert in global medical trials regulations. He has extensive experience in management and business development, having worked across the gamut of small technology ventures to industrial and government departments, and his qualifications include Master of Law, an MBA, and Master of Public Administration A member of several think tanks and NGOs, Denys holds a deep passion for world-changing technology.
Ada is a former venture fund analyst and has previously interned as a research analyst at a major European hedge fund. She has a BA in Economics (Boston University) and MSc in Finance (Bocconi University). As an analyst, she assisted biotech startups to build their financial models, develop investment materials and attract further financing.
A Doctor of Medicine (MD), Arkadii graduated from the Odesa National Medical University and is a practicing surgeon. He is a materials patents author, a researcher in 3D bioprinting, and one of the longest-serving employees of A.D.A.M. As Head of R&D, Arkadii is responsible for medical planning, design, material choice, patents, production, and trials of the bone and tissue implants.
Yuliya graduated from Donetsk National University with a degree in law, specializing in jurisprudence. A legal adviser and project manager, she has extensive experience working with governments, large enterprises, and IT startups. Yuliya is a Partner at Digital Lawyers Ltd.
Dmytro is a 3D-printing industry expert, having been involved in sales, business development, and advisory positions for several 3D printing companies. He has a Masters in Law, and has advised Stanley Black & Decker in relation to launching the International Additive Manufacturing Center, opening 2024 in Connecticut.
Markian is a Corporate Counsel with over thirty years of international experience. He is a corporate attorney, co-founder of multiple multinational entities, and former Partner with Dentons. Markian specializes in general corporate law, mergers and acquisitions, and international transactions.
Research & Development Team Project Manager Michael is an engineer focusing on thermal processing and materials chemistry. Previously he was an R&D engineer for 3D printing ceramics, and as a ceramics specialist also lectured in the subject at the prestigious Southukrainian National State Pedagogical University.
Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 2 of 5 annual reports (FY2021–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGAR- Form DOct 18, 20230001865086-23-000004EDGAR
- Form D/AOct 18, 20230001865086-23-000005EDGAR
- Form C-TRApr 26, 20230001665160-23-000798EDGAR
- Form C-ARApr 25, 20230001665160-23-000772EDGAR
- Form C-UMay 4, 20220001665160-22-001565EDGAR
- Form C-ARApr 29, 20220001665160-22-001271EDGAR
- Form C/AApr 20, 20220001665160-22-000689EDGAR
- Form C/ADec 6, 20210001665160-21-002144EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.